Skip to content
APIKIT/
ProductModelsQuick StartAbout
中文Log inGet started ↗
ProductModelsQuick StartAboutLog inSign up
LAUNCH OFFERGet a $1 free credit on sign-upOne key for GPT / Claude / Gemini and 50+ modelsApplied automatically · Email or Google sign-inClaim free→
APIKIT / NEWS

Hassabis' Isomorphic Labs Raises $5 Billion

2026-11-18 · bing_en

60-Second Overview

ItemDetails
CompanyIsomorphic Labs
PersonDemis Hassabis
Funding$5 billion
FocusAI-driven drug discovery
ContextHassabis left as Google DeepMind CEO months ago

Key Points

  • Isomorphic Labs announced $5 billion in funding; investors and valuation are subject to official announcements.
  • The company aims to accelerate drug discovery using AI, not to build general-purpose large models.
  • Demis Hassabis stepped down as Google DeepMind CEO months before this funding round.
  • The event signals continued capital interest in AI applications for life sciences.

What It Means for Developers

For developers, this funding signals that AI drug discovery is moving from research to engineering. Companies like Isomorphic Labs require significant compute, data pipelines, and model deployment capabilities, likely involving molecular simulation, protein structure prediction, and generative models. While most developers are not directly involved in drug R&D, the pattern of AI landing in vertical domains is worth watching.

On the other hand, Hassabis' departure and new venture show that top AI talent is moving faster, and the boundary between large-model companies and industry application companies is blurring. Developers can keep an eye on open-source tools and APIs in AI drug discovery, which may eventually be called through unified interfaces like general-purpose models.

How to Follow Up

  1. Watch Isomorphic Labs' official announcements for funding details and partners.
  2. Track open-source models and datasets in AI drug discovery to understand technical routes.
  3. Assess whether your business involves biological or molecular data and consider integrating relevant AI capabilities.

FAQ

What does Isomorphic Labs do?

Isomorphic Labs is a company using AI to develop new medicines, led by Demis Hassabis. Specific business scope is subject to official announcements.

Does this funding matter to ordinary developers?

Direct impact is limited, but the tech stack and API ecosystem of AI drug discovery may bring new integration opportunities worth long-term attention.

Why did Hassabis leave Google DeepMind?

The source material does not specify the reason; refer to official announcements.

Call Models on APIKIT

If you want to quickly integrate AI capabilities into your applications, you can use APIKIT for unified access. One API Key lets you call Claude, GPT, Gemini, DeepSeek, Kimi, Qwen, and other models without managing separate keys and interfaces for each platform.

Call models on APIKIT

APIKIT offers unified AI model access: one API key for Claude, GPT, Gemini, DeepSeek, Kimi, Qwen and more, OpenAI-compatible at official pricing, Sign up · Browse models

← Back to news

APIKIT/

APIKIT is an AI API gateway for developers and teams: one account and one key give you OpenAI-compatible access to GPT, Claude, Gemini, Grok, DeepSeek and 50+ leading models, with routing, availability monitoring, key and quota isolation, and token-level usage analytics.

ProductProductModelsConsole
ResourcesQuick startWorkBuddy guideModel plazaAccount
CompanyAboutPrivacyTerms
Contact usContact supportTelegram supportsupport@apikit.ccHours 13:00–01:00
Friend LinksFRIEND LINKS · 36All links & link exchange →
  • 零点导航
  • 188网址导航
  • 我的网址导航
  • 樱花导航
  • 联网分类目录
  • 耗叔收录网
  • 星云导航
  • 9893收录网
  • 灵汐收录网
  • UC网址导航
  • 流量导航网
  • DM网址大全
  • 网链网
  • 笛链导航
  • 128导航网
  • 奇点导航
  • 久零导航
  • 站牌导航
  • 162100网址导航
  • 36K导航
  • iQ网上导航
  • 991网址导航
  • 199导航网
  • 龙腾收录网
  • 文成收录网
  • 爱收集导航
  • 来福利啦
  • 爱尔美站长
  • 三体网址大全
  • 顺为导航
  • 天之翼导航
  • AI工具网
  • V6游戏导航
  • 新云导航网
  • 狐狸导航
  • 懒大王导航
© 2026 APIKIT. All rights reserved.BUILT FOR WHAT COMES NEXT ↗